Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.
FORD MOTOR CO
FGenerated Aug 19, 2026, 10:30 PM UTC
F (FORD MOTOR CO) analytical snapshot. Revenue grew +1.2% YoY to $187.27B. 5-year revenue CAGR +6.6%; 10y CAGR +2.4%. Net margin at -4.36% (contracting ▼). Market cap $54.05B at $14.50 per share. FCF DCF intrinsic value ≈ $57.54 → implied upside +296.8%. DCF assumptions: Base FCF $12.47B; Stage-1 growth 8.00% for 5y; Terminal growth 2.50%; Discount rate 10.00%. Risk: Elevated. Macro: Risk-on · Supportive. Composite analytical score 3 (data confidence 83%). Descriptive analytics from public filings — not investment advice.
Free SEC analysis
— computed from SEC filings, free to readFilings & Ownership
Latest annual report (10-K) filed Feb 11, 2026. Latest quarterly report (10-Q) filed Jul 29, 2026. 17 recent 8-K material-event filings in the index.
- Latest annual report (10-K) filed Feb 11, 2026.
- Latest quarterly report (10-Q) filed Jul 29, 2026.
- 17 recent 8-K material-event filings in the index.
- Recent insider Form 4s: 0 buy vs 0 sell transactions.
- ~10,000+ recent 13F-HR filings reference FORD MOTOR CO; broad institutional reporting.
- Recent filers include INVESTORS TRUST CO /PA, INVESTORS TRUST CO /PA, INVESTORS TRUST CO /PA.
- 20 recent 13G passive institutional ownership notices.
| Filer | Form | Filed |
|---|---|---|
| INVESTORS TRUST CO /PA | 13F-HR | Feb 15, 2002 |
| INVESTORS TRUST CO /PA | 13F-HR | Oct 12, 2001 |
| INVESTORS TRUST CO /PA | 13F-HR | Jul 12, 2001 |
| P&S CAPITAL PARTNERS LLC | 13F-HR | May 15, 2002 |
| PROVIDENT INVESTMENT ADVISORS INC | 13F-HR | Oct 22, 2002 |
| Date | Form | Description |
|---|---|---|
| Jul 28, 2026 | 8-K | 8-K |
| Jul 2, 2026 | 8-K | 8-K |
| May 21, 2026 | 8-K | 8-K |
| May 19, 2026 | 8-K | 8-K |
| Apr 29, 2026 | 8-K | 8-K |
| Apr 15, 2026 | 8-K | 8-K |
| Apr 15, 2026 | 8-K | 8-K |
| Apr 2, 2026 | 8-K | 8-K |
SEC Filing Deep-Analysis
4 risk signal(s), 1 positive signal(s) detected from XBRL filing diff analysis. 4 risk signal(s) detected versus 1 positive signal(s). The balance of evidence suggests elevated filing-specific risk that warrants monitoring in subsequent filings.
- NEW: Going concern doubt in latest filing: The term "going concern" "substantial doubt" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 5 filing(s).
- Material weakness in internal controls: The term "material weakness" "internal control" appears in 5 recent filing(s) (vs 2 in the prior period). This risk language is ongoing.
- NEW: Substantial doubt about ability to continue in latest filing: The term "substantial doubt" "ability to continue" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 5 filing(s).
- Restatement of financial statements: The term "restatement of" "previously issued" appears in 5 recent filing(s) (vs 1 in the prior period). This risk language is ongoing.
- Deferred revenue growing — future revenue visibility: Deferred revenue grew +34.8% to $4.49B, providing forward revenue visibility. This is a positive leading indicator for subscription or contract-based businesses.
- Endogenous analysis: 4 risk signal(s) detected versus 1 positive signal(s). The balance of evidence suggests elevated filing-specific risk that warrants monitoring in subsequent filings.
- 1 new XBRL disclosure(s) in latest filing — expanding reporting scope.
- 20 disclosure(s) dropped from prior year — reduced reporting granularity.
- 2 new risk-language term(s) detected in filing text: Going concern doubt, Substantial doubt about ability to continue.
- Ongoing high-severity risk language: Material weakness in internal controls, Restatement of financial statements.
| Metric | Prior year | Latest year | Change | % Change |
|---|---|---|---|---|
| Revenue | $184.99B | $187.27B | $2.27B | +1.2% |
| Operating income | $5.22B | $-9.17B | $-14.39B | -275.7% |
| Net income | $5.88B | $-8.16B | $-14.04B | -238.8% |
| Operating cash flow | $15.42B | $21.28B | $5.86B | +38.0% |
| Capex | $8.68B | $8.81B | $131.0M | +1.5% |
| Total assets | $285.20B | $289.16B | $3.96B | +1.4% |
| Total liabilities | $240.34B | $253.18B | $12.84B | +5.3% |
| Long-term debt | $470.0M | $291.0M | $-179.0M | -38.1% |
| Cash & equivalents | $22.93B | $23.36B | $421.0M | +1.8% |
| Stockholders equity | $44.84B | $35.95B | $-8.88B | -19.8% |
| Inventory | $14.95B | $15.29B | $334.0M | +2.2% |
| Accounts receivable | $14.72B | $15.40B | $675.0M | +4.6% |
| R&D expense | $8.00B | $9.40B | $1.40B | +17.5% |
| SG&A expense | $10.29B | $10.85B | $562.0M | +5.5% |
| Interest expense | $4.59B | $7.61B | $3.02B | +65.8% |
| Type | Concepts |
|---|---|
| Added | FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss |
| Removed | AdjustmentForAmortization, AdvertisingExpense, AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount, AssetImpairmentCharges, CostOfPropertyRepairsAndMaintenance, CurrentFederalTaxExpenseBenefit, CurrentForeignTaxExpenseBenefit, CurrentIncomeTaxExpenseBenefit, CurrentStateAndLocalTaxExpenseBenefit, DeferredFederalIncomeTaxExpenseBenefit |
| Term | Severity | Recent | Prior | Status |
|---|---|---|---|---|
| Going concern doubt | high | 5 | 0 | NEW |
| Material weakness in internal controls | high | 5 | 2 | Ongoing |
| Substantial doubt about ability to continue | high | 5 | 0 | NEW |
| Restatement of financial statements | high | 5 | 1 | Ongoing |
| Impairment charge | medium | 5 | 2 | Ongoing |
| Restructuring | medium | 5 | 8 | Ongoing |
| Off-balance sheet arrangements | medium | 5 | 2 | Ongoing |
| Related party transactions | low | 5 | 2 | Ongoing |
Fundamentals
Revenue grew +1.2% YoY to $187.27B. 5-year revenue CAGR +6.6%; 10y CAGR +2.4%. Net margin at -4.36% (contracting ▼).
- Revenue grew +1.2% YoY to $187.27B.
- 5-year revenue CAGR +6.6%; 10y CAGR +2.4%.
- Net margin at -4.36% (contracting ▼).
- Return on equity -22.70%, ROA -2.82%, ROIC -25.50%.
- Gross margin 0.00%, operating margin -4.90%.
- Free cash flow margin 6.66% ($12.47B).
- Net income down ▼ +238.8% YoY.
- Debt/equity 0.01, current ratio 1.09, net debt -$17.36B.
- Asset turnover 0.66 — capital efficiency.
| FY | Revenue | Rev YoY | Gross% | Op% | Net% | FCF | ROE% |
|---|---|---|---|---|---|---|---|
| 2024 | $184.99B | +5.0% | 0.00 | 2.82 | 3.18 | $6.74B | 13.11 |
| 2025 | $187.27B | +1.2% | 0.00 | -4.90 | -4.36 | $12.47B | -22.70 |
| Quarter end | Revenue | YoY | QoQ | Net margin |
|---|---|---|---|---|
| Mar 31, 2021 | $36.23B | +5.6% | — | — |
| Jun 30, 2021 | $26.75B | +38.1% | -26.2% | — |
| Sep 30, 2021 | $35.68B | -4.8% | +33.4% | — |
| Mar 31, 2022 | $34.48B | -4.8% | -3.4% | -9.02% |
| Jun 30, 2022 | $40.19B | +50.2% | +16.6% | 1.66% |
| Sep 30, 2022 | $39.39B | +10.4% | -2.0% | -2.10% |
Pro analysis — preview
— score, signals & key metrics shown; full reasoning lockedValuation
Market cap $54.05B at $14.50 per share. FCF DCF intrinsic value ≈ $57.54 → implied upside +296.8%. DCF assumptions: Base FCF $12.47B; Stage-1 growth 8.00% for 5y; Terminal growth 2.50%; Discount rate 10.00%.
- Market cap $54.05B at $14.50 per share.
Price & Technicals
Price $14.50 — uptrend (above 200-DMA); 1-month momentum positive. RSI(14) 44.00.
- Price $14.50 — uptrend (above 200-DMA); 1-month momentum positive.
Macro & Rates
Risk-on · Supportive. Real GDP growth 1.50% (quarterly, as of Apr 1, 2026). CPI inflation +3.3% YoY. Fed funds rate 3.63%, 10Y Treasury 4.71%.
- Market regime: Risk-on · Supportive.
Risk Scorecard
Composite risk Elevated. Leverage debt/equity 0.01 (low). Liquidity current ratio 1.09 (adequate).
- Composite risk: Elevated.
See the full picture behind every stock
Unlock the complete 10-year fundamentals, DCF & Graham intrinsic value, 13F/13D ownership flow, risk scorecard, multi-analyst bull/bear debate — plus watchlist alerts and your research workspace. Start with a 14-day Pro trial.
3 sections free · 4 Pro previews · composite 3
Macro exposure
Mixed cyclical · Moderate sensitivityMacro regime: Risk-on · Supportive. FORD MOTOR CO is a mixed cyclical name (moderate macro sensitivity) — risk appetite favors cyclical/growth names.
Analytical read
deterministic previewMarket cap $54.05B at $14.50 per share..